The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
Scholarship for a College Fee 2018
Invest for children has offered a new scholarship to study a Graphic Design Degree at Barcelona Elisava School of Design and Engineering. With this i4c pretends to promote school and…
see project 
